Evaluation of Parotid Salivary Gland Echo Texture by Ultrasound Examinations and Correlation With Whole-Body Scintigraphy After Radioiodine Therapy in Patients With Differentiated Thyroid Carcinoma

J Ultrasound Med. 2020 Sep;39(9):1811-1818. doi: 10.1002/jum.15289. Epub 2020 Apr 20.

Abstract

Objectives: This study aimed to evaluate the echo texture of the parotid salivary glands before and after radioiodine therapy (RIT) using ultrasound (US) images in patients with differentiated thyroid cancer and to evaluate the correlations between post-RIT whole-body scintigraphy (WBS) images and US image patterns in salivary and cervical areas.

Methods: A retrospective study was performed with data on demographic and clinical information, US examinations, and WBS images collected through medical recordings.

Results: Comparing the US features before and after RIT, significant echo texture heterogeneity was found in 31.3% of all patients evaluated. When evaluated according to the level of iodine 131 (I-131) radioactivity (<5.6, 5.6-<9.3, and ≥9.3 GBq), echo texture heterogeneity was significantly associated with the 5.6-GBq I-131 radioactivity group (P < .001). No association was found for any level of I-131 post-RIT WBS uptake intensity and changes in US feature patterns.

Conclusions: Ultrasound may be a useful tool for evaluating chronic sialadenitis after RIT, and the I-131 uptake intensity using a routine post-RIT WBS is not associated with US echo texture changes.

Keywords: iodine 131; sialadenitis; thyroid cancer; ultrasound; whole-body scintigraphy.

MeSH terms

  • Humans
  • Iodine Radioisotopes* / therapeutic use
  • Radionuclide Imaging
  • Retrospective Studies
  • Salivary Glands / diagnostic imaging
  • Thyroid Neoplasms* / diagnostic imaging
  • Thyroid Neoplasms* / radiotherapy

Substances

  • Iodine Radioisotopes
  • Iodine-131